Zurich Australia has released a Supplementary Product Disclosure Statement applying to its Zurich Active product range.
Relating to a minor change to the definition of carcinoma in situ, and presumably added in order to deliver greater clarity and transparency, the definition now contains an additional section which outlines certain elements or conditions that are not included in the carcinoma in situ definition.
Click here to access the one-page SPDS, dated 10 February 2023, which is also now included in the current Zurich Active Product Disclosure Statement dated 27 September 2021.
